Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study

被引:0
|
作者
Barth, D. [1 ]
Moik, F. [1 ]
Steinlechner, S. M. [1 ]
Posch, F. [2 ]
Schlintl, V. [1 ]
Koch, L. [3 ]
John, N. [4 ]
Wurm, R. [4 ]
Pichler, M. [1 ]
Bauernhofer, T. [1 ]
Reimann, P. [5 ]
Wohlkoenig, C. [4 ]
Richtig, E. [3 ]
Winder, T. [5 ]
Preusser, M. [6 ]
Jost, P. J. [1 ]
Ay, C. [7 ]
Gerger, A. [1 ]
Terbuch, A. [1 ]
Riedl, J. M. [1 ]
机构
[1] Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria
[2] Med Univ Graz, Div Hematol, Dept Internal Med, Graz, Austria
[3] Med Univ Graz, Dept Dermatol, Graz, Austria
[4] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria
[5] Landeskrankenhaus Feldkirch, Dept Oncol, Feldkirch, Austria
[6] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria
[7] Med Univ Vienna, Dept Med 1, Clin Div Haematol & Haemostaseol, MedUni Wien, Vienna, Austria
关键词
D O I
10.1016/j.annonc.2023.09.2917
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
194P
引用
收藏
页码:S259 / S259
页数:1
相关论文
共 50 条
  • [31] Patterns of C-Reactive Protein Response to Antibiotic Therapy in Severe Community-Acquired Pneumonia Patients: A Cohort Study
    Coelho, L.
    Povoa, P.
    Soares, M.
    Bozza, F.
    Verdeal, J.
    Castro-Faria-Neto, H.
    Lapa e Silva, J.
    Bozza, P.
    Salluh, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [32] Treatment patterns and outcomes in KRASG12C-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study
    Barghout, Samir H.
    Zhan, Luna Jia
    Raptis, Starvroula
    Al-Agha, Faisal
    Esfahanian, Niki
    Popovacki, Aimee
    Kasymjanova, Goulnar
    Proulx-Rocray, Francis
    Chan, Sze Wah Samuel
    Richardson, Matthew
    Brown, M. Catherine
    Patel, Devalben
    Dean, Michelle Liane
    Navani, Vishal
    Moore, Erica
    Carvery, Lane
    Yan, Elizabeth
    Goldshtein, Daniel
    Cleary-Gosine, Jasmine
    Gibson, Amanda J. W.
    Hubley, Lynn
    Balaratnam, Karmugi
    Ngo, Tran
    Gill, Azee
    Black, Morgan
    Sacher, Adrian
    Bradbury, Penelope A.
    Shepherd, Frances A.
    Leighl, Natasha
    Cheema, Parneet
    Kuruvilla, Sara
    Agulnik, Jason
    Banerji, Shantanu
    Juergens, Rosalyn
    Blais, Normand
    Cheung, Winson
    Wheatley-Price, Paul
    Liu, Geoffrey
    Snow, Stephanie
    LUNG CANCER, 2024, 194
  • [33] Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospective multi-center cohort study
    Zhang, Feng
    Wang, Yong-Shuai
    Li, Shao-Peng
    Zhao, Bin
    Huang, Nan
    Song, Rui-Peng
    Meng, Fan-Zheng
    Feng, Zhi-Wen
    Zhang, Shen-Yu
    Song, Hua-Chuan
    Chen, Xiao-Peng
    Liu, Lian-Xin
    Wang, Ji-Zhou
    JOURNAL OF GASTROENTEROLOGY, 2024, : 442 - 455
  • [34] Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study
    Zhang, Bo
    Yu, Yuanhang
    Hubert, Shawna M.
    Zhang, Yue
    Lu, Jianhua
    Liu, Shihua
    Xie, Fang
    Zhao, Liang
    Lei, Xiao
    Deng, Wei
    Chen, Jianying
    Li, Yunqiao
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [35] Effect of sodium-glucose transport protein 2 inhibitors on all-cause mortality in patients with gout: A multi-center cohort study
    Chan, Shu-Yen
    Ma, Kevin Sheng-Kai
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [36] Usefulness of Early C-Reactive Protein Kinetics in Response and Prognostic Assessment in Infected Critically III Patients: An Observational Retrospective Study
    Pereira, Marta Ayres
    Rouxinol-Dias, Ana Lidia
    Vieira, Tatiana
    Paiva, Jose Artur
    Pereira, Jose Manuel
    ACTA MEDICA PORTUGUESA, 2019, 32 (12) : 737 - 745
  • [37] Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
    Tiu, Bruce C.
    Zubiri, Leyre
    Iheke, James
    Pahalyants, Vartan
    Theodosakis, Nicholas
    Ugwu-Dike, Pearl
    Seo, Jayhyun
    Tang, Kimberly
    Sise, Meghan E.
    Sullivan, Ryan
    Naidoo, Jarushka
    Mooradian, Meghan J.
    Semenov, Yevgeniy R.
    Reynolds, Kerry L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [38] EARLY RESPONSE AT FOUR WEEKS OF C-REACTIVE PROTEIN PREDICTS SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS
    Yasuda, Yosuke
    Saito, Kazutaka
    Kawamura, Naoko
    Uehara, Sho
    Yuasa, Takeshi
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Yamamoto, Shinya
    Takahashi, Shunji
    Okuno, Tetsuo
    Yonese, Junji
    Kihara, Kazunori
    Fujii, Yasuhisa
    JOURNAL OF UROLOGY, 2017, 197 (04): : E181 - E181
  • [39] External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort
    Tamura, Keita
    Osawa, Takahiro
    Takeuchi, Ario
    Minami, Keita
    Nakai, Yasutomo
    Ueda, Kosuke
    Ozawa, Michinobu
    Uemura, Motohide
    Sugimoto, Mikio
    Ohba, Kojiro
    Suzuki, Toshihiro
    Anai, Satoshi
    Shindo, Tetsuya
    Kusakabe, Naohisa
    Komiyama, Motokiyo
    Tanaka, Ken
    Yokomizo, Akira
    Kohei, Naoki
    Shinohara, Nobuo
    Miyake, Hideaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) : 810 - 818
  • [40] Timing of cutaneous immunerelated adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study
    Rashdan, Hannah
    Zhang, Shijia
    Wan, Guihong
    Nguyen, Nga
    Roster, Katie
    Rajeh, Ahmad
    Tang, Kimberly
    Chen, Wenxin
    Moseley, Cameron
    Chen, Steven
    Leboeuf, Nicole
    Semenov, Yevgeniy R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (05) : 1080 - 1083